Compound diisopropylamine dichloroacetate injection
Function and Efficacy
1. Effects on fatty liver (1) Consuming liver fat: This product is decomposed into diisopropylamine and dichloroacetic acid in the body. The former generates methionine under the activation of ATP, and the latter is metabolized to glycine. Under the action of glycine lyase, N5N10-CH2-FH4 (methyltetrahydrofolate) is generated, which provides energy at the same time. Both can provide methyl groups to promote choline synthesis. Choline reacts with liver fat to generate lecithin, which promotes the decomposition of liver fat. (2) Transporting liver fat: Lecithin, liver fat, and cholesterol combine with apolipoproteins to form lipoproteins. Lipoproteins are easily soluble in plasma, thereby transporting fat from the liver to the outside of the liver and reducing the accumulation of fat in the liver. (3) This product can reduce arterial blood
Ingredients
This product is a compound preparation, and its composition is: each 1ml contains 20mg of diisopropylamine dichloroacetate and 19mg of sodium gluconate.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Diisopropylammonium dichloroacetateIngredients |
It is decomposed into diisopropylamine and dichloroacetic acid in the body. The former generates methionine, and the latter is metabolized into glycine, which promotes choline synthesis. Choline reacts with liver fat to generate lecithin, which promotes the decomposition of liver fat. At the same time, it reduces related substances in arterial blood. More |
660-27-5 | 14 | |
| Sodium gluconateIngredients |
The specific pharmacological effect is not clear, and it may be involved in basic metabolic support or auxiliary function More |
527-07-1 | 13 |
Appearance
This product is a colorless clear liquid.
Indication
Liver-protecting medicine. Used for fatty liver, intrahepatic cholestasis, and general liver dysfunction. Used for acute and chronic hepatitis, hepatomegaly, and early cirrhosis.
Usage and Dosage
Calculated as diisopropylamine dichloroacetate. Intramuscular injection 40mg once, 1-2 times a day; intravenous injection 40mg once, 1-2 times a day; intravenous drip 40-80mg once, 1-2 times a day, diluted with 5% or 10% glucose solution or 0.9% sodium chloride solution to an appropriate amount (50ml-100ml). Please follow the doctor's advice for the course of treatment.
Adverse Reactions
Occasionally, you may experience dizziness, thirst, loss of appetite, etc., but these symptoms may disappear on their own.
Precautions
People who are allergic to this product are prohibited from using it. If an allergic reaction occurs, the symptoms will disappear after stopping the drug.
Drug Interactions
There are no special contraindications.
Storage
Keep away from light and store in a sealed container.
Packaging Specification
2ml:40mg
Manufacturer
Hunan Wzt Pharmaceutical Co., Ltd.
-
Founded in:
2000-02-29 -
Address:
No. 219, Biquantan Road, Tianyi Economic Development Zone, Xiangtan, Hunan Province -
Tax NO.:
91430300740629832Q -
Registered Funds:
8.08 million yuan -
Website:
-
Email: